Epidermal Growth Factor Receptor (Egfr) and Abcg2 Polymorphisms and Treatment Outcome in the Randomized Phase III Torch Trial in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients

Geoffrey Liu, Francesco Perrone, Ming‐Sound Tsao et al.|Annals of Oncology|2014

Cited by 0